Rare diseases
Investigational molecules
Locations
47 Thorndike Street Suite B1-1, 02141-1799, United States
Leap Therapeutics Inc. focuses on gastric adenocarcinoma and gastroesophageal junction cancer, with research centred on advanced and inoperable disease. Its clinical activity includes treatment settings for locally advanced and metastatic disease, reflecting interest in hard-to-treat upper gastrointestinal malignancies.
The sponsor’s research in this area is linked to combination approaches involving immunotherapy and chemotherapy for patients with advanced disease.
Leap Therapeutics Inc. runs clinical trials in conditions such as Colorectal cancer metastatic, Colorectal cancer, Adenocarcinoma gastric, Gastrooesophageal cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
